Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-118938
Filing Date
2020-10-28
Accepted
2020-10-28 16:11:51
Documents
1
Period of Report
2020-10-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2034345d1_3.html 3  
1 OWNERSHIP DOCUMENT tm2034345d1_3.xml 3 1569
  Complete submission text file 0001104659-20-118938.txt   3053
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 66 WEST 38TH STREET, APT. 19D NEW YORK NY 10018
Business Address
Kirschbaum Mark (Reporting) CIK: 0001830211 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 201268765